Physician

Matthew D. Karl, MD

According to 2025 Medicare claims, Matthew Karl, MD (NPI: 1154716959) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is SIGHT MEDICAL DOCTORS PLLC (NPI: 1487077483; TIN: 46-4449523) and primary practice location at 11787-9998. Karl is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Karl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,558 traditional Medicare patients, billed 45,079 HCPCS/CPT codes, and received $2,612,655 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 455 prescription claims across 149 beneficiaries totaling $45,135 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,234 to $2,612,655. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,115 to $45,135. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	26	37	$2,234
2020	50	66	$5,982
2021	217	1,044	$120,530
2022	464	2,916	$430,931
2023	939	12,851	$691,706
2024	1,558	45,079	$2,612,655

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	17	49	$2,115
2016	35	113	$9,965
2017	74	414	$36,645
2018	74	480	$42,408
2019	91	344	$28,749
2020	118	294	$15,237
2021	83	252	$13,614
2022	92	236	$12,267
2023	57	158	$73,997
2024	149	455	$45,135

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	870	947	$113
67028	Injection of drug into eye	318	1,161	$111
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	481	592	$79
92012	Established patient problem focused exam of visual system	506	659	$79
92134	Imaging of retina	1,484	3,092	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	135	2,203	$4,045
Difluprednate	Difluprednate	23	583	$3,285
Bromfenac Sodium	Bromfenac Sodium	14	362	$1,708
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	20	716	$1,640
Atropine Sulfate	Atropine Sulfate	30	769	$1,022

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$131	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew D. Karl, MD?

Tedicare shows public-source Medicare data for Matthew D. Karl, MD (NPI 1154716959), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew D. Karl, MD have ACO affiliation data?

Matthew D. Karl, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Matthew D. Karl, MD?

Matthew D. Karl, MD is linked to SIGHT MEDICAL DOCTORS PLLC (billing NPI 1487077483) in the available physician profile data.

Does Matthew D. Karl, MD have Open Payments data?

Matthew D. Karl, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.